Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders

J Autism Dev Disord
October 2000
https://www.ncbi.nlm.nih.gov/pubmed/?term=11098883

Naltrexone in autistic children: behavioral symptoms and attentional learning

J Am Acad Child Adolesc Psychiatry
November 1993
https://www.ncbi.nlm.nih.gov/pubmed/?term=8282676

Objective: To assess critically the short-term efficac y and safety of naltrexone in autistic children and its effects on discrimination learning in the laboratory.

Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children

Eur Neuropsychopharmacol
June 1999
https://www.ncbi.nlm.nih.gov/pubmed/?term=10422898

Naltrexone in autistic children: an acute open dose range tolerance trial

J Am Acad Child Adolesc Psychiatry
March 1989
http://www.ncbi.nlm.nih.gov/pubmed/?term=2925573

Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone

Encephale
Mar-Apr 1993
http://www.ncbi.nlm.nih.gov/pubmed/8275903

Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children

Psychopharmacol Bull
1993
https://pubmed.ncbi.nlm.nih.gov/8290669/

Naltrexone and communication skills in young children with autism

J Am Acad Child Adolesc Psychiatry
May 1999
https://pubmed.ncbi.nlm.nih.gov/10230191/

Objective: To evaluate the effect of naltrexone on communication skills of young children with autism.

Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design

J Autism Dev Disord
April 1999
https://pubmed.ncbi.nlm.nih.gov/10382138/

Naltrexone open trial with a 5-year-old-boy. A social rebound reaction

Acta Paedopsychiatr
1992
https://pubmed.ncbi.nlm.nih.gov/1414352/

Naltrexone and other potential new pharmacological treatments of autism

Brain Dysfunction
April 1991
https://psycnet.apa.org/record/1993-26766-001